The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation
Open accessAbstract
G-protein-coupled receptors (GPCRs) modulate many physiological processes by transducing a variety of extracellular cues into intracellular responses. Ligand binding to an extracellular orthosteric pocket propagates conformational change to the receptor cytosolic region to promote binding and activation of downstream signalling effectors such as G proteins and β-arrestins. It is well known that different agonists can share the same binding pocket but evoke unique receptor conformations leading to a wide range of downstream responses (‘efficacy’). Furthermore, increasing biophysical evidence, primarily using the β2-adrenergic receptor (β2AR) as a model system, supports the existence of multiple active and inactive conformational states. However, how agonists with varying efficacy modulate these receptor states to initiate cellular responses is not well understood. Here we report stabilization of two distinct β2AR conformations using single domain camelid antibodies (nanobodies)—a previously described positive allosteric nanobody (Nb80) and a newly identified negative allosteric nanobody (Nb60). We show that Nb60 stabilizes a previously unappreciated low-affinity receptor state which corresponds to one of two inactive receptor conformations as delineated by X-ray crystallography and NMR spectroscopy. We find that the agonist isoprenaline has a 15,000-fold higher affinity for β2AR in the presence of Nb80 compared to the affinity of isoprenaline for β2AR in the presence of Nb60, highlighting the full allosteric range of a GPCR. Assessing the binding of 17 ligands of varying efficacy to the β2AR in the absence and presence of Nb60 or Nb80 reveals large ligand-specific effects that can only be explained using an allosteric model which assumes equilibrium amongst at least three receptor states. Agonists generally exert efficacy by stabilizing the active Nb80-stabilized receptor state (R80). In contrast, for a number of partial agonists, both stabilization of R80 and destabilization of the inactive, Nb60-bound state (R60) contribute to their ability to modulate receptor activation. These data demonstrate that ligands can initiate a wide range of cellular responses by differentially stabilizing multiple receptor states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The absence of the L chain means that the nanobody’s CDRs are distinct from those of antibodies in both sequence and structure, and as a result nanobodies are able to bind antibody-inaccessible epitopes in enzyme active sites, viral capsids and G protein coupled receptors [233, 234].”
From Computational approaches to therapeutic antibody design: established methods and emerging trends (2020) · cites this paper as [233]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,001
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Self-citationBallesteros, J. A., & Weinstein, H. (1995) · Methods in neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 3,001
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,709
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 335
Exploring the kinetic selectivity of drugs targeting the β 1 ‐adrenoceptor
Sykes, D. A., Jiménez‐Rosés, M., Reilly, J., Fairhurst, R. A., Charlton, S. J., & Veprintsev, D. B. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.978 · Cited by 11
Chen, J., Wang, J., Zeng, Q., Wang, W., Sun, H., & Wei, B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.972463 · Cited by 11
Intracellular VHHs to monitor and modulate GPCR signaling
Raynaud, P., Gauthier, C., Jugnarain, V., Jean‐Alphonse, F., Reiter, É., Bruneau, G., & Crépieux, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1048601 · Cited by 11
Soave, M., Cseke, G., Hutchings, C. J., Brown, A., Woolard, J., & Hill, S. J. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.015 · Cited by 11
Development of covalent antagonists for β1- and β2-adrenergic receptors
Schwalbe, T., Huebner, H., & Gmeiner, P. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.05.034 · Cited by 11
Goulding, J., Mistry, S. J., Soave, M., Woolard, J., Briddon, S. J., White, C. W., Kellam, B., & Hill, S. J. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.779 · Cited by 13
Allosteric Modulators for GPCRs as a Therapeutic Alternative with High Potential in Drug Discovery
Reyes‐Alcaraz, A., Garcia-Rojas, E. Y. L., Bond, R. A., & McConnell, B. K. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91838 · Cited by 10
Nikte, S. V., Sonar, K., Tandale, A., Joshi, M., & Sengupta, D. (2021) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2021.140605 · Cited by 10
Hu, W., Wang, H., Hou, Y., Hao, Y., & Liu, D. (2019) · FEBS Letters · doi:10.1002/1873-3468.13382 · Cited by 10
Finding the Perfect Fit: Conformational Biosensors to Determine the Efficacy of GPCR Ligands
Olson, K. M., Campbell, A., Alt, A. J., & Traynor, J. R. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00256 · Cited by 10
Weng, D., Yang, L., & Xie, Y. (2024) · Protein Expression and Purification · doi:10.1016/j.pep.2024.106501 · Cited by 10
Yang, M. Y., Mac, K. D., Strzelinski, H. R., Hoffman, S. J., Kim, D., Kim, S., Su, J., Liggett, S. B., & Goddard, W. A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409987121 · Cited by 9
Artificial Intelligence: A New Tool for Structure-Based G Protein-Coupled Receptor Drug Discovery
Chung, J., Hahn, H., Flores-Espinoza, E., & Thomsen, A. R. B. (2025) · Biomolecules · doi:10.3390/biom15030423 · Cited by 9
Turcotte, M. G., Samuelsson, A., Possidento, S. M., Li, J., Qin, Z., Kapiloff, M. S., & Dodge‐Kafka, K. L. (2025) · Circulation · doi:10.1161/circulationaha.124.072682 · Cited by 9
Formation of pH‐Resistant Monodispersed Polymer–Lipid Nanodiscs
Ravula, T., Hardin, N. Z., Ramadugu, S. K., Cox, S. J., & Ramamoorthy, A. (2017) · Angewandte Chemie · doi:10.1002/ange.201712017 · Cited by 9
Wiseman, D. N., Samra, N., Lara, M. M. R., Penrice, S., & Goddard, A. D. (2021) · Pharmaceuticals · doi:10.3390/ph14100953 · Cited by 9
Jespers, W., Heitman, L. H., IJzerman, A. P., Sotelo, E., van Westen, G. J. P., Åqvist, J., & Gutiérrez‐de‐Terán, H. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009152 · Cited by 12
Histamine H3 Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity
Gao, M., Ooms, J. F., Leurs, R., & Vischer, H. F. (2024) · Biomolecules · doi:10.3390/biom14070761 · Cited by 10
Biased Allosteric Modulation in GPCR Drug Discovery
Zhou, J.-C., Li, M., Long, A., & Kahsai, A. W. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_771 · Cited by 8
Self-citationSmith, A. A., Pacull, E. M., Stecher, S., Hildebrand, P. W., Vogel, A., & Huster, D. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202302003 · Cited by 8
Coupling and Activation of the β1 Adrenergic Receptor - The Role of the Third Intracellular Loop
Qiu, X., Chao, K., Song, S., Wang, Y., Chen, Y., Rouse, S. L., Yen, H., & Robinson, C. V. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c11250 · Cited by 9
Vilchis‐Landeros, M. M., Guinzberg, R., Riveros‐Rosas, H., Villalobos‐Molina, R., & Piña, E. (2020) · FEBS Letters · doi:10.1002/1873-3468.13763 · Cited by 8
G Protein-Coupled Receptors in Osteoarthritis: A Novel Perspective on Pathogenesis and Treatment
Wen, Z., Liu, D., Zhang, Y., Cai, Z., Xiao, W., & Li, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.758220 · Cited by 8
In silico discovery of nanobody binders to a G-protein coupled receptor using AlphaFold-Multimer
Harvey, E. P., Smith, J. S., Hurley, J. D., Granados, A. J., Schmid, E. W., Liang-Lin, J. G., Zhang, H., Meara, E. M., Wren, E. K., Paul, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72093-5 · Cited by 7
Self-citationNanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations
Watson, S., Harvey, E. P., Pishesha, N., Ploegh, H. L., & Springer, T. A. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110374 · Cited by 7
Recent Developments in the Optical Control of Adrenergic Signaling
Shi, S., Cao, Y., Wijtmans, M., Vischer, H. F., & Leurs, R. (2025) · Medicinal Research Reviews · doi:10.1002/med.22110 · Cited by 7
Insights into Comparative Modeling of VHH Domains
Vattekatte, A. M., Cadet, F., Gelly, J., & de Brevern, A. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189771 · Cited by 7
Protein Design Strategies for the Structural–Functional Studies of G Protein-Coupled Receptors
Dmitrieva, D. A., Kotova, T. V., Safronova, N. A., Sadova, A. A., Dashevskii, D. E., & Mishin, A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923140110 · Cited by 7
Conner, J., Poole, D. P., Jörg, M., & Veldhuis, N. A. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0327 · Cited by 9
Structural insights into the unique recognition module between α‐synuclein peptide and nanobody
Islam, Z., Vaikath, N. N., Hmila, I., El‐Agnaf, O. M. A., & Kolatkar, P. R. (2023) · Protein Science · doi:10.1002/pro.4875 · Cited by 6
Allosteric nanobodies to study the interactions between SOS1 and RAS
Fischer, B., Uchański, T., Sheryazdanova, A., González, S., Volkov, A. N., Brosens, E., Zögg, T., Kalichuk, V., Ballet, S., Versées, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50349-2 · Cited by 8
Self-citationShang, Z., Ding, D., Deng, Z., Zhao, J., Yang, M., Xiao, Y., Chu, W., Xu, S., Zhang, Z., Yi, X., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202417280 · Cited by 6
Nanobodies as sensors of GPCR activation and signaling
Daibani, A. E., & Che, T. (2021) · Methods in cell biology · doi:10.1016/bs.mcb.2021.06.008 · Cited by 6
Weber, D. K., & Veglia, G. (2019) · Australian Journal of Chemistry · doi:10.1071/ch19307 · Cited by 6
Advances in NMR Methods to Identify Allosteric Sites and Allosteric Ligands
Abdelkarim, H., Hitchinson, B., Banerjee, A., & Gaponenko, V. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8719-7_8 · Cited by 6
Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity
McMullan, M., Kelly, B., Mihigo, H. B., Keogh, A. P., Rodrı́guez, F., Brocos‐Mosquera, I., García‐Bea, A., Miranda-Azpiazu, P., Callado, L. F., & Rozas, I. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112947 · Cited by 6
Saleh, N., Ibrahim, P., & Clark, T. (2017) · Angewandte Chemie · doi:10.1002/ange.201702468 · Cited by 6
Bourque, K., Dallagnol, J. C. C., Nassour, H., Chatenet, D., Allen, B. G., & Hébert, T. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819771-4.00008-7 · Cited by 6
Yokoi, S., & Mitsutake, A. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00862-1 · Cited by 5
Dye‐Based Fluorescent Organic Nanoparticles, New Promising Tools for Optogenetics
Lesas, J., Bienvenu, T., Kurek, E., Verlhac, J., Grivet, Z., Têtu, M., Girard, D., Lanore, F., Blanchard-Desce, M. H., Herry, C., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402132 · Cited by 5
Inside-out receptor inhibition
Sakmar, T. P., & Huber, T. (2016) · Nature · doi:10.1038/nature20486 · Cited by 5
Illuminating the Path to Target GPCR Structures and Functions
Nielsen, C. D. ‐., Dhasmana, D., Floresta, G., Wohland, T., & Cilibrizzi, A. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00606 · Cited by 5
A Bridge to Alkaloid Synthesis
Zhai, L., Tang, Y. H., Zhang, Y., Huang, S., Zhu, L., & Hong, R. (2021) · The Chemical Record · doi:10.1002/tcr.202100197 · Cited by 5
Nakamura, I., Amesaka, H., Hara, M., Yonezawa, K., Okamoto, K., Kamikubo, H., Tanaka, S., & Matsuo, T. (2023) · Protein Science · doi:10.1002/pro.4813 · Cited by 5
Elgeti, M., Belyaeva, J., Helabad, M. B., Staus, D. P., & Wingler, L. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111117 · Cited by 4
Self-citationG-Protein/Receptor inhibitors as blockers of receptor signaling
Kenakin, T. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.07.014 · Cited by 4
Kurihara, Y., Ekimoto, T., Gordon, C. T., Uchijima, Y., Sugiyama, R., Kitazawa, T., Iwase, A., Kotani, R., Asai, R., Pingault, V., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci151536 · Cited by 4
Zhang, Y. L., Zhao, Y., Dai, L., Liu, Y., & Shi, Z. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2441 · Cited by 4
Galdino, G. T., Mailhot, O., & Najmanovich, R. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00788 · Cited by 3
NMR Spectroscopy for the Characterization of GPCR Energy Landscapes
Casiraghi, M., Banères, J., & Catoire, L. J. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2017_31 · Cited by 4
Lawson, A. D. G., MacCoss, M., Baeten, D., Macpherson, A., Shi, J., & Henry, A. J. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.668186 · Cited by 4
Ehlert, F. J., & Stein, R. S. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.09.007 · Cited by 4
Application of Biomolecular Simulations to G Protein–Coupled Receptors ( GPCRs )
Torrens‐Fontanals, M., Stępniewski, T. M., Rodríguez‐Espigares, I., & Selent, J. (2018) · Methods and principles in medicinal chemistry · doi:10.1002/9783527806836.ch8 · Cited by 4
Raynaud, P., Jugnarain, V., Vaugrente, O., Vallet, A., Boulo, T., Gauthier, C., Inoue, A., Sibille, N., Gauthier, C., Jean‐Alphonse, F., et al. (2023) · FEBS Letters · doi:10.1002/1873-3468.14765 · Cited by 6
Nanoscale spatiotemporal cluster analysis of expressed and endogenous proteins
Gormal, R. S., Wallis, T. P., McCann, A. J., Kudo, K., Jiang, A., Syed, P., Longfield, S. F., Amor, R., & Meunier, F. A. (2025) · Nature Protocols · doi:10.1038/s41596-025-01209-w · Cited by 3
Hamed, O., Jayasinghe, V., & Giembycz, M. A. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001920 · Cited by 3
Shpakov, A. O. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023070013 · Cited by 3
Computational Exploration of Conformational Transitions in Protein Drug Targets
Cossins, B. P., Lawson, A. D. G., & Shi, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7756-7_17 · Cited by 3
A 19F-qNMR-Guided Mathematical Model for G Protein-Coupled Receptor Signaling
Giraldo, J., Madsen, J. J., Wang, X., Wang, L., Zhang, C., & Ye, L. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000754 · Cited by 3
Exploring the Binding Mechanism of ADGRG2 Through Metadynamics and Biochemical Analysis
Zhang, C., Zhang, R., Qi, Y., Wen, X., Sun, J., & Xiao, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010167 · Cited by 3
Optical approaches for visualization of arrestin binding to muscarinic receptor
Jung, S., & Hille, B. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2017.11.001 · Cited by 3
Nanobody‐Enabled Reverse Pharmacology on G‐Protein‐Coupled Receptors
Pardon, E., Betti, C., Laeremans, T., Chevillard, F., Guillemyn, K., Kolb, P., Ballet, S., & Steyaert, J. (2018) · Angewandte Chemie · doi:10.1002/ange.201712581 · Cited by 3
Self-citationThe many faces of G protein-coupled receptors
Kingwell, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.179 · Cited by 3
Design and Preparation of Photobodies: Light-Activated Single-Domain Antibody Fragments
Yilmaz, Z., Jedlitzke, B., & Mootz, H. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2075-5_21 · Cited by 3
Structure‐Based Drug Design for G Protein‐Coupled Receptors
Congreve, M., Christopher, J. A., & de Graaf, C. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc269 · Cited by 3
Duan, J., Xu, P., Zhang, H., Luan, X., Yang, J., Mao, C., Shen, D., Ji, Y., He, X., Cheng, X., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.01.502312 · Cited by 3
Fischer, B., Uchański, T., Sheryazdanova, A., González, S., Volkov, A. N., Brosens, E., Zögg, T., Kalichuk, V., Ballet, S., Versées, W., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.06.519258 · Cited by 3
Self-citationNavanukraw, P., Chotimanukul, S., Udomthanaisit, L., Setthawong, P., Saehlee, S., Seetaha, S., Choowongkomon, K., & Chatdarong, K. (2024) · Theriogenology · doi:10.1016/j.theriogenology.2024.06.005 · Cited by 3
Homology Modeling of the G Protein-Coupled Receptors
Mordalski, S., & Kościółek, T. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2974-1_9 · Cited by 2
Verma, A., & Mondal, P. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107386 · Cited by 2
NMR-based approaches to the study of GPCRs and GPCR-ligand interactions
Pandey, A. N., Larda, S. T., LaPlante, S. R., & Prosser, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00004-0 · Cited by 2
Self-citationGarcia-Rojas, E. Y. L., Reyes‐Alcaraz, A., Ruan, K.-H., McConnell, B. K., & Bond, R. A. (2022) · FASEB BioAdvances · doi:10.1096/fba.2022-00038 · Cited by 1
Shpakov, A. O. (2023) · Журнал эволюционной биохимии и физиологии · doi:10.31857/s0044452923070021 · Cited by 2
Crystal structure of the potassium channel MtTMEM175 with cesium
Brunner, J. D., Jakob, R. P., Schulze, T., Neldner, Y., Moroni, A., Thiel, G., Maier, T., & Schenck, S. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6hda/pdb · Cited by 2
Monitoring Ligand-Induced Changes in Receptor Conformation with NanoBiT Conjugated NanobodiesPreprint
Soave, M., Heukers, R., Kellam, B., Woolard, J., Smit, M. J., Briddon, S. J., & Hill, S. J. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3578138 · Cited by 2
Vasopressin V2 is a promiscuous G protein-coupled receptor that is biased by its peptide ligandsPreprint
Heydenreich, F. M., Plouffe, B., Rizk, A., Milić, D., Zhou, J., Breton, B., Gouill, C. L., Inoue, A., Bouvier, M., & Veprintsev, D. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.28.427950 · Cited by 2
Selective Affimers Recognize BCL-2 Family Proteins Through Non-Canonical Structural MotifsPreprint
Miles, J. A., Hóbor, F., Taylor, J. W., Tiede, C., Rowell, P. R., Trinh, C. H., Jackson, B. R., Nadat, F., Kyle, H. F., Wicky, B. I. M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/651364 · Cited by 3
Heterodimers Revolutionize the Field of Metabotropic Glutamate ReceptorsPreprint
Balkacemi, K., Rondard, P., Pin, J., & Prézeau, L. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4760564 · Cited by 2
Computational design of allosteric pathways reprograms ligand-selective GPCR signalingPreprint
Hijazi, M., Kéri, D., Oggier, A., Sengar, A., Agosto, M. A., Wensel, T. G., & Barth, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.13.670154 · Cited by 3
Reiter, É. (2021) · Biologie Aujourd hui · doi:10.1051/jbio/2021010 · Cited by 1
Design of Drug Efficacy Guided by Free Energy Simulations of the β 2 ‐Adrenoceptor
Panel, N., Vo, D. D., Kahlous, N. A., Hübner, H., Tiedt, S., Matricon, P. G., Pacalon, J., Fleetwood, O., Kampen, S., Luttens, A., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202218959 · Cited by 2
Fallon, B. S., Rondem, K. E., Mumby, E. J., & English, J. G. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00871 · Cited by 1
Lloyd, J. R., Varughese, A. S., Kapoor, P., Duerr, K. L., Yen, H., Jazayeri, A., Hopper, J. T. S., & Oldham, N. J. (2025) · Chemical Science · doi:10.1039/d5sc05107j · Cited by 1
Multi-dimensional orchestration of binders for improved CAR-T immunotherapy
Zhu, C., Jiang, Z. H., Jing, R., Guo, W., & Lu, Y. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218699 · Cited by 1
Zang, J., Wang, S., Xu, K., Zhan, X., Tian, Y., Yao, X., & Liu, H. (2026) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.70083 · Cited by 1
Structures of Non-rhodopsin GPCRs Elucidated Through X-Ray Crystallography
Nasrallah, C., & Lebon, G. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2017_28 · Cited by 1
Optogenetic Activation of Intracellular Nanobodies
Yu, D., & Heo, W. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2075-5_31 · Cited by 1
Agonists in the Extended Conformation Stabilize the Active State of β-Adrenoceptors
Efimov, A. V., Meshcheryakova, O. V., & Ryazanov, A. G. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922070057 · Cited by 1
Characterizing Conformational Diversity of G Protein-coupled Receptors by Solution NMR Spectroscopy
Wu, F., Bumbak, F., Tanipour, M. H., Asadollahi, K., Vaid, T. M., Sethi, A., Scott, D. J., & Gooley, P. R. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165702-00346 · Cited by 1
G Protein-Coupled Receptor–Ligand Pose and Functional Class Prediction
Szwabowski, G. L., Griffing, M. C., Mugabe, E. J., O’Malley, D., Baker, L. N., Baker, D. L., & Parrill, A. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136876 · Cited by 1
Semenova, Y. V., Eliseeva, N. V., & Спасов, А. А. (2020) · Journal of Volgograd State Medical University · doi:10.19163/1994-9480-2020-4(76)-141-145 · Cited by 1
Wu, F., Williams, L. M., Abdul‐Ridha, A., Gunatilaka, A., Vaid, T. M., Kočan, M., Whitehead, A. R., Griffin, M. D. W., Bathgate, R. A. D., Scott, D. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/866475 · Cited by 1
Bourque, K., Frohlich, E., & Hébert, T. E. (2022) · Wiley eBooks · doi:10.1002/9781119564782.ch4 · Cited by 1
Grosskopf, J. D., Kasson, P. M., & Lerch, M. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.05.658127 · Cited by 1
Norman, R. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Solid-State Nuclear Magnetic Resonance Spectroscopy of Membrane Proteins
Wang, S., Xu, X., & Yang, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-6823-2_9
Byrd, R. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002666117
Molecular mechanism of analgesic bias on μ-opioid receptorPreprint
Sun, Y., Wang, W., Shao, S., Tian, X., Li, Y., Tan, B., Fu, W., & Su, R. (2020) · doi:10.22541/au.158447859.96547606
Pharmacological Receptor Theory
Kenakin, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00010-4
Kenakin, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00026-8
Metadata
- Authors
- Staus, D. P., Strachan, R. T., Manglik, A., Pani, B., Kahsai, A. W., Kim, T. H., Wingler, L. M., Ahn, S., Chatterjee, A., Masoudi, A., Kruse, A. C., Pardon, E., Steyaert, J., Weis, W. I., Prosser, R. S., Kobilka, B. K., Costa, T., & Lefkowitz, R. J.
- Affiliations
- Duke Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- Stanford Medicine (US)
- University of Toronto (CA)
- Harvard University (US)
- Vrije Universiteit Brussel (BE)
- Istituto Superiore di Sanità (IT)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Kobilka, Brian K.
- Costa, Tommaso
- Lefkowitz, Robert J.
- ORCID
- Venue
- Nature
- Published
- 2016-07
- Volume
- 535
- Issue
- 7612
- Pages
- 448-452
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4961583
- OpenAlex
- W2471992026
- Cited by
- 330
- References
- 38
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 23 · 2023: 28 · 2022: 26 · 2021: 46 · 2020: 36 · 2019: 47 · 2018: 43 · 2017: 39 · 2016: 13
- FWCI
- 25.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- American Heart Association
- Ministero della Salute (02351158, RF-201102351158)
- National Heart, Lung, and Blood Institute (HL 16037, R01HL070631, HL-70631, T32HL007101, R01HL016037)
- National Institute of General Medical Sciences (T32GM008294)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007731)
- National Institute of Neurological Disorders and Stroke (NS-028471, R01NS028471, R37NS028471)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- beta2-adrenergic receptor, G protein-coupled receptor activation, receptor conformational states, three-state model, partial agonists, full agonists, ligand efficacy, receptor stabilization, orthosteric binding pocket, receptor dynamics
- MeSH terms
- Allosteric Regulation, Allosteric Site, Humans, Isoproterenol, Ligands, Models, Molecular, Protein Conformation, Receptors, Adrenergic, beta-2, Crystallography, X-Ray, Nuclear Magnetic Resonance, Biomolecular, Drug Partial Agonism, Protein Stability, Adrenergic beta-2 Receptor Agonists, Single-Domain Antibodies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
